Monoclonal antibodies (mAbs) prevent, detect, and treat a broad spectrum of non-communicable and infectious diseases. Over the past few years, the...
Vous n'êtes pas connecté
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.
Monoclonal antibodies (mAbs) prevent, detect, and treat a broad spectrum of non-communicable and infectious diseases. Over the past few years, the...
Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on...
Monoclonal antibodies (mAbs) are special proteins used to help prevent, detect, and treat a wide range of diseases, both infectious and...
A groundbreaking study has revealed a promising new approach to prostate cancer treatment. The nanoparticle-based therapy, guided by laser...
Tissue stiffness in HER2-negative breast cancer, the most common type, can directly contribute to disease progression and metastasis, which can have...
Discover how mini-proteins deliver targeted radiation to Nectin-4 expressing tumor cells, sparing healthy tissues and offering new hope for cancer...
A new study has revealed that a short course of chemotherapy before radiation therapy can significantly improve survival rates for cervical cancer...
Report promotes a collaborative four pillar approach to address community safety interventions. In partnership with the HKLN Drug Strategy, the...
Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and...
RAHWAY, N.J., Oct. 17, 2024 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of...